Cargando…
Current status of molecular-targeted drugs for endometrial cancer (Review)
Endometrial cancer is a common gynecological malignant tumor in Western countries and its incidence has also been on the increase in Asia. Genetic abnormalities related to onset and progression of malignancy in the endometrial membrane and signaling system have been identified and the developmental...
Autores principales: | NOGAMI, YUYA, BANNO, KOUJI, KISU, IORI, YANOKURA, MEGUMI, UMENE, KIYOKO, MASUDA, KENTA, KOBAYASHI, YUSUKE, YAMAGAMI, WATARU, NOMURA, HIROYUKI, TOMINAGA, EIICHIRO, SUSUMU, NOBUYUKI, AOKI, DAISUKE |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915661/ https://www.ncbi.nlm.nih.gov/pubmed/24649249 http://dx.doi.org/10.3892/mco.2013.140 |
Ejemplares similares
-
Candidate Biomarkers for Genetic and Clinicopathological Diagnosis of Endometrial Cancer
por: Banno, Kouji, et al.
Publicado: (2013) -
New candidate therapeutic agents for endometrial cancer: Potential for clinical practice (Review)
por: UMENE, KIYOKO, et al.
Publicado: (2013) -
Aurora kinase inhibitors: Potential molecular-targeted drugs for gynecologic malignant tumors (Review)
por: Umene, Kiyoko, et al.
Publicado: (2019) -
Endometrial Cancer and Hypermethylation: Regulation of DNA and MicroRNA by Epigenetics
por: Banno, Kouji, et al.
Publicado: (2012) -
Methylation Analysis of DNA Mismatch Repair Genes Using DNA Derived from the Peripheral Blood of Patients with Endometrial Cancer: Epimutation in Endometrial Carcinogenesis
por: Takeda, Takashi, et al.
Publicado: (2016)